LOGIN  |  REGISTER
Assertio
Chimerix

DBV Technologies: Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024

June 04, 2024 | Last Trade: US$10.83 0.16 -1.46

Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345

 

Date

 
Total number of shares Total number of voting rights
05/31/2024

 
96,493,078

 
 

Total gross of voting rights: 96,493,078

 
 

Total net* of voting rights: 96,236,383

 

* Net total = total number of voting rights attached to shares – shares without voting rights

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page